Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Can Regeneron (REGN) Keep the Earnings Surprise Streak Alive?
01:33pm, Wednesday, 06'th Apr 2022
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Regeneron Builds On Retinal Disease Expertise Via Gene Therapy Pact With ViGeneron
11:31am, Wednesday, 06'th Apr 2022
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) beefed up its gene therapy capabilities after signing a new deal with the German biotech ViGeneron. The companies did not specify their target but note
7 Safe Stocks to Buy to Guard Against a Recession
06:17pm, Tuesday, 05'th Apr 2022
It's not too late to buy safe stocks. These seven stocks, all A-rated, are perfect plays for riding out continued volatility in the markets.
Regeneron to Report First Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2022
04:05pm, Tuesday, 05'th Apr 2022
TARRYTOWN, N.Y , April 5, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2022 financial and operating results on Wednesday,
Ari Wald on Regeneron: it's one of my favourite charts in biotech
04:03pm, Tuesday, 05'th Apr 2022
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) hit an all-time high on Tuesday but an Oppenheimer analyst says it might just be the beginning of what's yet to come. Ari Wald sees another 15% upside in R
Three Buys & a Bail: REGN, WMT, AMZN & FDX
02:18pm, Tuesday, 05'th Apr 2022
Oppenheimer's Ari Wald joins 'The Exchange' to discuss three stocks he likes and one he doesn't.
Regeneron (REGN), Sanofi Get Priority Review for Dupixent sBLA
12:03pm, Monday, 04'th Apr 2022
The FDA accepts and grants priority review to Regeneron (REGN) and Sanofi's sBLA for Dupixent to treat eosinophilic esophagitis in patients aged 12 years and older. A decision is due on Aug 3, 2022.
Regeneron, IGM Biosciences Shares Up Big on Sanofi Deals
04:52pm, Thursday, 31'st Mar 2022
A week filled with promising announcements failed to jump-start Sanofi SA's ( SNY , Financial) shares, but it did for the two companies it's working with.
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
11:31pm, Tuesday, 29'th Mar 2022
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
AstraZeneca (AZN) Gets EU Nod for COVID-19 Antibody Cocktail
04:31pm, Monday, 28'th Mar 2022 Zacks Investment Research
The European Commission approves AstraZeneca's (AZN) Evusheld for the pre-exposure prophylaxis of COVID-19 infection in a broad patient population.
Market Rally Pauses But Still Healthy; Marriott Worldwide, Regeneron, Carlisle Near Buy Points
04:05pm, Friday, 25'th Mar 2022
Market rally pauses but still healthy; Marriott Worldwide, Regeneron, Carlisle near buy points. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock li
3 Top Stock-Split Candidates After Amazon and Alphabet
09:52am, Friday, 25'th Mar 2022 The Motley Fool
These companies haven't said they'll split their stocks, but the topic should be on their minds.
3 Top Stock-Split Candidates After Amazon and Alphabet
05:52am, Friday, 25'th Mar 2022
These companies haven't said they'll split their stocks, but the topic should be on their minds.
Amazon Stock Split: 3 Companies That Should Follow Suit
03:07pm, Thursday, 24'th Mar 2022 The Motley Fool
These stocks are all trading at more than $500.
Regeneron Searching For A New High
10:08pm, Tuesday, 22'nd Mar 2022
88% technical buy signals. 8 new highs and up 15.01% in the last month.
